Home > Boards > US Listed > Biotechs > Anavex Life Sciences Corp (AVXL)

Hey McM,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
RHF469usa Member Profile
 
Followed By 1
Posts 111
Boards Moderated 0
Alias Born 10/29/15
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 8/7/2019 4:07:28 PM
Anavex Life Sciences Reports Fiscal 2019 Third Quarter Financial Results And Provides Clinical Study Updates GlobeNewswire Inc. - 8/7/2019 7:00:00 AM
Anavex Life Sciences to Announce Fiscal 2019 Third Quarter Financial Results on Wednesday, August 7th, 2019 GlobeNewswire Inc. - 8/2/2019 7:00:00 AM
Anavex Life Sciences Reports Recent Data Review by the Independent Data Safety Monitoring Board for its U.S. Phase 2 Clinical... GlobeNewswire Inc. - 7/31/2019 7:00:00 AM
Anavex Life Sciences Receives Positive Opinion for Orphan Designation from the European Medicines Agency for ANAVEX®2-73 for... GlobeNewswire Inc. - 7/29/2019 7:00:00 AM
Anavex Life Sciences Presents New Clinical Data Identifying Gut Microbiota Biomarkers Associated with Improved Clinical Respo... GlobeNewswire Inc. - 7/17/2019 11:45:00 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 7/16/2019 6:01:11 AM
Biotech Companies with Recent and Potential Near-Term Catalysts InvestorsHub NewsWire - 7/15/2019 8:15:00 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 7/3/2019 4:33:43 PM
Anavex Life Sciences Announces First Patient Dosed in Extension Study to its U.S. Phase 2 Clinical Trial of ANAVEX®2-73 in P... GlobeNewswire Inc. - 6/25/2019 7:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/12/2019 5:02:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2019 4:59:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/6/2019 7:28:42 PM
Anavex Life Sciences Announces First Patient Dosed in Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Rett Syndro... GlobeNewswire Inc. - 6/6/2019 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2019 6:12:48 AM
Rett Syndrome Association of Australia and Anavex Life Sciences Announce Initiation of the Phase 2 AVATAR Clinical Study in P... GlobeNewswire Inc. - 5/8/2019 8:00:00 AM
Anavex Life Sciences Reports Fiscal 2019 Second Quarter Financial Results and Provides Clinical Study Updates GlobeNewswire Inc. - 5/8/2019 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/7/2019 4:33:58 PM
Anavex Life Sciences to Announce Fiscal 2019 Second Quarter Financial Results on Wednesday May 8th, 2019 GlobeNewswire Inc. - 5/6/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/8/2019 4:40:20 PM
Anavex Life Sciences to Present at the H.C. Wainwright Annual Global Life Sciences Conference GlobeNewswire Inc. - 4/5/2019 4:01:00 PM
Anavex Life Sciences Presents Data On ANAVEX®2-73 in Alzheimer’s Disease at the American Society for Experimental Neurothe... GlobeNewswire Inc. - 3/28/2019 7:00:00 AM
Industry Consortium Launched to Qualify Biomarkers for Schizophrenia Drug Development Business Wire - 3/20/2019 9:00:00 AM
Anavex Life Sciences Announces First Patient Dosed in Phase 2 Clinical Trial of ANAVEX®2-73 for the Treatment of Rett Syndro... GlobeNewswire Inc. - 3/18/2019 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/18/2019 6:28:15 AM
RHF469usa   Tuesday, 10/10/17 11:43:03 AM
Re: None
Post # of 206345 
Hey McM,
You should put up that petition every day or a couple times a day as some folks tune in briefly then out again.
Thanks for posting that.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist